Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Aspirin-Exacerbated Respiratory Disease

Although previous numbers for aspirin-exacerbated respiratory disease (AERD) have varied widely, new findings suggest that it is present in approximately 7% of the adult asthmatic patient population, with that number doubled in patients with severe asthma.

Lung Infections May Hamper Cancer Detection

A test used to diagnose lung cancer may not be as reliable in geographic regions where certain lung infections are more common.

Fetal BPA Exposure and Childhood Wheeze

Exposure in pregnancy to bisphenol A (BPA) may increase a child's risk of respiratory issues, with a 10-fold increase in the average amount of BPA in the mothers' urine linked to a nearly 55% increase in the odds of some type of wheezing in their children.

Asthma Risk and Job Loss Fear

Perceived job insecurity during an economic downturn may increase the risk of newly onset asthma.

Sense of Smell May Predict Mortality

Olfaction could predict 5-year mortality risk among older adults, suggests a new study.

FDA Warning on Asthma Drug

The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with Xolair.

Asthma Treatments: Inhalations

Review this updated chart on inhalations for asthma treatment for quick information when you need it.

New Drug Product: Breo Ellipta

Long term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema.


FDA Clears New Flu, RSV Dx Molecular Test

Cepheid announced it has received clearance from the Food and Drug Administration (FDA) to market Xpert Flu/RSV XC, a molecular test for determination for Flu A and B, and differentiation of respiratory syncytial virus (RSV) infection.

Dr. Reddy's Launches Generic Allegra-D 12 Hour

Dr. Reddy's Laboratories announced the launch of Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets, the generic version of Chattem's Allegra-D 12 Hour.

Nutrition Tx for COPD Patients Reduces Hospital Stay, Cost

Patients with chronic obstructive pulmonary disease (COPD) aged ≥65 years who received nutrition treatment had reduced lengths of stay, hospital costs, and probability of readmission within 30-days, according to results of a study published in CHEST.

Lung Cancer CT Screening for Long-Time Smokers May Be Covered by Medicare

Annual lung cancer screenings for long-term smokers may soon be covered by Medicare, the U.S. Centers for Medicare & Medicaid Services announced.

Featured courses from mycme

Achieving and Sustaining Asthma Control in the Community SettingExternal web site

In this activity, experts will review the role of inflammation in both the large and ...

CME|CPE|CE 1.50 Credits

Asthma and COPD: Providing Optimal Management (Pharmacology Credit)External web site

This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...

CE 1.50 Credits

Sign Up for Free e-newsletters